Transplantace krvetvorných buněk
- MUDr. Pavel Jindra, Hematologicko-onkologické oddělení FN Plzeň
- prof. MUDr. Jiří Mayer, CSc., Interní hematoonkologická klinika FN Brno, Brno
Effect of total nucleated and CD34+ cell dose on outcome after allogeneic hematopoietic stem cell transplantation
Otevřít | 2015 | prof. MUDr. Marta Krejčí, Ph.D.
Single-agent high-dose cyclophosphamide for graft-versus-host disease prophylaxis in human leukocyte antigen-matched reduced-intensity peripheral blood stem cell transplantation results in an unacceptably high rate of severe acute graft-versus-host disease
Otevřít | 2015 | prof. MUDr. Marta Krejčí, Ph.D.
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
Otevřít | 2015 | prof. MUDr. Marta Krejčí, Ph.D.
Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoieitic cell transplantation: pharmacokinetics and clinical outcomes
Otevřít | 2013 | doc. MUDr. Marta Krejčí, Ph.D.
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
Otevřít | 2013 | doc. MUDr. Marta Krejčí, Ph.D.
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GvHD
Otevřít | 2013 | MUDr. Markéta Hadrabová
Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclofosfamide Versus Busulfan Plus Fludarabine
Otevřít | 2013 | MUDr. Zuzana Šustková
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation
Otevřít | 2013 | prof. MUDr. Marta Krejčí, Ph.D.
Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis
Otevřít | 2013 | prof. MUDr. Marta Krejčí, Ph.D.
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all groups
Otevřít | 2012 | MUDr. Zuzana Šustková
Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial
Otevřít | 2012 | MUDr. Zuzana Šustková
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Otevřít | 2012 | MUDr. Zuzana Šustková
An update to HLA Nomenclature, 2010
Otevřít | 2010 | MUDr. Zuzana Šustková
Severe events in donors after allogeneic hematopoietic stem cell donation
Otevřít | 2009 | MUDr. František Folber
Intitial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
Otevřít | 2009 | MUDr. František Folber
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Otevřít | 2009 | MUDr. Štěpán Hrabovský
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
Otevřít | 2008 | MUDr. František Folber
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Otevřít | 2008 | MUDr. František Folber
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
Otevřít | 2008 | MUDr. František Folber
The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation
Otevřít | 2008 | MUDr. František Folber
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
Otevřít | 2008 | MUDr. František Folber
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor
Otevřít | 2008 | MUDr. František Folber
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
Otevřít | 2008 | MUDr. František Folber
Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies
Otevřít | 2008 | MUDr. František Folber
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia
Otevřít | 2008 | MUDr. František Folber
HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated stem cell transplantation.
Otevřít | 2008 | MUDr. Pavel Jindra
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Otevřít | 2008 | MUDr. Pavel Jindra
Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor after autologous and allogeneic stem cell transplantation
Otevřít | 2006 | prof. MUDr. Jiří Mayer, CSc.